Lijun Tian

ORCID: 0009-0009-1517-1906
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Treatments and Mutations
  • Paraoxonase enzyme and polymorphisms
  • Pediatric health and respiratory diseases
  • Lung Cancer Research Studies
  • Apelin-related biomedical research
  • Nuclear Receptors and Signaling
  • Cancer Immunotherapy and Biomarkers
  • Anorectal Disease Treatments and Outcomes
  • Advanced Radiotherapy Techniques
  • Pelvic floor disorders treatments
  • Cytokine Signaling Pathways and Interactions
  • Neonatal Respiratory Health Research
  • Food Chemistry and Fat Analysis
  • Medicinal Plant Pharmacodynamics Research
  • Oral health in cancer treatment
  • Synthesis and Biological Evaluation
  • Cancer-related molecular mechanisms research
  • Food composition and properties
  • Tissue Engineering and Regenerative Medicine
  • Gastrointestinal motility and disorders
  • Colorectal and Anal Carcinomas
  • NF-κB Signaling Pathways
  • Advanced biosensing and bioanalysis techniques
  • Reproductive Biology and Fertility

Binzhou University
2015-2024

Binzhou Medical University
2015-2024

Inner Mongolia University of Science and Technology
2022-2024

Baotou Medical College
2022

Tianjin Medical University
2022

Shanxi Medical University
2009-2021

Shaanxi Provincial People's Hospital
2009-2021

Agriculture and Food
2021

Commonwealth Scientific and Industrial Research Organisation
2021

Third Hospital of Hebei Medical University
2019

PURPOSE This multicenter, randomized, phase III clinical trial (Northern Radiation Oncology Group of China-002) focused on patients with oligo-organ metastatic non–small cell lung cancer (NSCLC) who have epidermal growth factor receptor ( EGFR ) mutations. We aimed to investigate whether first-line concurrent thoracic radiotherapy (TRT) and EGFR-tyrosine kinase inhibitors (TKIs), compared TKIs alone, could achieve better survival. MATERIALS AND METHODS The in the TKI plus TRT group received...

10.1200/jco.23.02075 article EN Journal of Clinical Oncology 2024-10-07

Patients with Eastern Cooperative Oncology Group performance status (ECOG PS) 2 probably cannot tolerate chemotherapy or other antitumor therapies. Some studies have reported that immunotherapy combined antiangiogenic therapy is well-tolerated and shows good activity. However, the efficacy of this combination as a later-line in patients ECOG PS unclear. This study evaluated effectiveness safety strategy third- further-line stage IV non-small cell lung cancer (NSCLC) 2.

10.1002/cam4.7349 article EN cc-by Cancer Medicine 2024-06-01

To retrospectively analyze and compare the outcomes of patients with hepatocellular carcinoma treated either surgical excision or CyberKnife® from September 2006 to August 2011.Local control toxicity were primary endpoints, followed by local progression-free survival, overall survival as secondary endpoints. Response Evaluation Criteria In Solid Tumors evaluation criteria for efficacy; Common Toxicity 3.0 adverse events. Local was calculated using direct method (nonactuarial). The curves...

10.2147/ott.s51452 article EN cc-by-nc OncoTargets and Therapy 2013-10-01

miR-203 is known to target estrogen receptor α (ERα) in various cancer cell lines, such as MCF-7. However, whether regulates ERα and contributes the onset progression of osteoarthritis (OA) poorly understood. A combined protocol bilateral ovariectomy intra-articular monosodium iodoacetate injection was applied establish a postmenopausal OA model rats. Real-time quantitative polymerase chain reaction used detect mRNAs Western blotting exploited quantify expression levels on protein level....

10.1089/humc.2019.101 article EN Human Gene Therapy Clinical Development 2019-11-12

Neurogenic locus notch homolog protein (Notch) signaling mediates intracellular communication and may regulate cell fate decisions, including proliferation, differentiation, apoptosis. Mesenchymal stem cells (MSCs) possess immunomodulatory properties the potential for use in replacement treatments. The aim of present study was to evaluate therapeutic effects human placenta‑deviated MSCs (hPMSCs) asthma investigate mechanisms Notch mediated by transplanted MSCs. A Sprague‑Dawley rat ovalbumin...

10.3892/mmr.2018.8462 article EN Molecular Medicine Reports 2018-01-19

Small quantities of lipids accumulate in the white rice grains. These are grouped into non-starch lipid and starch fractions that affect properties through association with starch. Lysophosphatidylcholine (LPC) lysophosphatidylethanolamine (LPE) two major classes fractions. Using high-oleic grains, we investigated fatty-acid composition flour by LC-MS evaluated its impact on properties. In wild-type grain, nearly 50% fatty acids LPC LPE were palmitic acid (C16:0), over 20% linoleic (C18:2)...

10.3390/foods10061169 article EN cc-by Foods 2021-05-23

Episil is a bioadhesive barrier-forming liquid gel that can relieve mucositis caused by radiotherapy (RT) and effectively pain. The purpose of this trial to compare the efficacy safety in improving acute radiation dermatitis (ARD) patients with breast cancer. This study included who met criteria for postoperative RT primary end point was grade RD during treatment. A total 102 were study. grouped 2:1 ratio using randomized number table method: 67 received combined conventional skin care (the...

10.1002/cpt.3171 article EN Clinical Pharmacology & Therapeutics 2023-12-30

Uterus is an important reproductive organ for embryonic growth and development of viviparous animals. Its normal function regulated by complex endocrine system multiple genes. NRDR a retinoic acid metabolizing enzyme with strong retinol oxidation retinoaldehyde reduction activities. in the has been partially studied. In this study, expression distribution change different physiological states developmental stages mouse uterus will be clarified, so as to provide experimental basis further...

10.36899/japs.2024.4.0775 article EN The Journal of Animal and Plant Sciences 2024-06-04

To evaluate the efficacy and safety of combined-modality therapy for elderly patients with locally advanced non-small-cell lung cancer (NSCLC) invading chest wall.We retrospectively enrolled 21 (aged ≥60 years) NSCLC wall. For external beam radiotherapy (EBRT) primary tumor, 40Gy was applied supplemented iodine-125 seed implantation while 60Gy to lymph nodes mediastinum. Follow-up conducted every 3 months postoperatively. The related analytic parameters were change in tumor size, objective...

10.2147/cmar.s294313 article EN cc-by-nc Cancer Management and Research 2021-07-01

Abstract Background: Estrogen receptor (ESR1) mutations occur at a high frequency in metastatic breast tumors patients treated with hormonal therapy the setting. We do not know if these are involved metastasis. Experimental design and methods: generated ESR1 Y537S homozygous using CRISPR Casp-9 technology. Treatment synergy was evaluated Compusyn. Athymic mice were used tumor xenograft studies. ChIP-Seq transcriptome analyses performed. Results: mutation knock-in clones lentiviral stable...

10.1158/1538-7445.sabcs16-s4-02 article EN Cancer Research 2017-02-15

Abstract Background Our retrospective study aimed to evaluate the efficacy and safety of combined-modality therapy for tumor invading chest wall locally advanced non-small-cell lung cancer (NSCLC) in elderly. Methods We retrospectively enrolled 21 elderly patients (aged ≥ 60 years) with NSCLC diagnosed as wall. The prescription dose primary adopting external beam radiotherapy (EBRT) was given 40 Gy which supplemented iodine-125 seed implantation, meanwhile lymph nodes mediastinum undergoing...

10.21203/rs.3.rs-62265/v1 preprint EN cc-by Research Square (Research Square) 2020-09-08

e16086 Background: Concurrent chemoradiotherapy (CCRT) is the standard therapy for locally advanced unresectable esophageal squamous cell cancer (ESCC),However, some patients cannot tolerate or are unwilling to CCRT. The aim of this phase II trial was assess efficacy and safety tirelizumab combined with radiotherapy in ESCC. Methods: Key eligibility criteria were as follows: ESCC clinical stage Ⅱ-Ⅳa; aged 18 90 years; CCRT; ECOG performance status 0 1; performed radiotherapy: Involvement...

10.1200/jco.2023.41.16_suppl.e16086 article EN Journal of Clinical Oncology 2023-06-01
Yonggang Wang Lijun Tian Liyun Niu Jian-yong Yang Ana María Branco and 88 more A. Carlos Saraiva Akiharu Kurihara Masashi Watanabe Eva Schest Herwig Cerwenka Bernd Höfler Marcus Rigler T. Auer Katrin Dorr Hans-Jörg Mischinger Zheng Hu Gerd Silberhumer Georg Györi Christopher Burghuber Christoph Neumayer Martin Riegler Hironori Ohdaira Hiroshi Nimura Tetsuji Fujita Norio Mitsumori Naoto Takahashi Hideyuki Kashiwagi Norichika Narimiya Katsuhiko Yanaga I.A.J. van Doesburg D. Boerma Thomas L. Bollen Bert van Ramshorst M J Wiezer Hung-Kuang Wei Shin‐E Wang Yi-Ming Shyr Hsiuo-Shan Tseng Wan‐Chen Tsai Tien-Hua Chen Cheng‐Hsi Su Chew-Wun Wu Wing‐Yiu Lui Cesare Ruffolo Marco Scarpa Daniela Bassi Imerio Angriman Yu Bai Wei Lin Wang F. Ferenschild I. Dawson Eelco J. R. de Graaf Johannes H.W. de Wilt Geert W. M. Tetteroo Shunji Endo Kiyokazu Nakajima Kazuhiro Nishikawa Tsuyoshi Takahashi Yoshihito Souma Eiji Taniguchi Toshinori Ito Toshirou Nishida Chunbao Zhai Sara K. Story Ronald S. Chamberlain A. Anbalagan Shanmugasundaram Rajendran Vellayudham Vimal Raj Govindhasamy Rajarathinam Damodaran Jyotibasu Palanisamy Ravichandran Jeswanth Satyanesan Tirupporur Govindaswamy Balachandar Devy Gounder Kannan Rajagopal Surendran Vibha Varma Subash Gupta Arvinder S. Soin Samiran Nundy Chunyan Xu Jingjing Shen Jianying Shen W.J. Chen L.B. Wang A.A.F.A. Veenhof Rebecca P. M. Brosens Alexander Engel Donald L. van der Peet M. A. Cuesta R. Jakesz Gerhard Prager Sebastian F. Schoppmann Johannes Zacherl

10.1159/000252845 article EN Digestive Surgery 2009-01-01
Coming Soon ...